SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-002386
Filing Date
2024-01-08
Accepted
2024-01-08 21:46:09
Documents
1
Period of Report
2024-01-04

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm242318-4_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm242318-4_4seq1.xml 4 4009
  Complete submission text file 0001104659-24-002386.txt   5687
Mailing Address 300 PARK AVENUE 2ND FLOOR NEW YORK NY 10022
Business Address 300 PARK AVENUE 2ND FLOOR NEW YORK NY 10022 (646) 293-2100
SEELOS THERAPEUTICS, INC. (Issuer) CIK: 0001017491 (see all company filings)

IRS No.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O SEELOS THERAPEUTICS, INC. 300 PARK AVENUE, 12TH FLOOR NEW YORK NY 10022
Business Address
Pascoe Richard W (Reporting) CIK: 0001343266 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-22245 | Film No.: 24521611